Dublin, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The "Generative AI in Personalized Medicine Market 2025-2029" has been added to ResearchAndMarkets.com's offering.
The generative AI in personalized medicine market is anticipated to experience substantial growth, projected to increase by USD 8.45 billion from 2024 to 2029, with a remarkable compound annual growth rate (CAGR) of 41.1% during the forecast period. This market analysis offers an integrated review, highlighting market size, trends, growth drivers, challenges, and vendor analysis across approximately 25 vendors.
The current market landscape is shaped by rapid drug discovery and shorter development cycles, strategic collaborations, and increased capital influx. These factors act as key growth accelerators. Moreover, advancements in multimodal data accessibility and computational prowess are foundational enablers for market expansion.
Emerging trends such as the development of biological foundation models and AI factories are set to drive market growth. Additionally, the rise of multimodal AI solutions for holistic disease analysis and the shift towards in-silico clinical trials and digital twins will propel demand.
Comprehensive research combines primary and secondary data inputs from industry stakeholders. The report encompasses extensive market size data, segment analysis, and vendor evaluation, providing historical and forecast insights.
The generative AI in personalized medicine market is segmented as follows:
By Application:
- Drug discovery
- Disease diagnosis
- Genomic analysis
By End-user:
- Pharmaceutical
- Academic institutes
- Hospitals
- Diagnostic centers
By Therapeutic Area:
- Oncology
- Neurology
- Cardiology
- Rare diseases
- Infectious diseases
By Geographical Landscape:
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the generative AI in personalized medicine market covers:
- Market sizing and forecasting
- Industry analysis
The vendor analysis aims to bolster market positioning, offering a meticulous review of leading companies such as Ardigen S.A., BenevolentAI, Google LLC, Insilico Medicine, Microsoft Corp., NVIDIA Corp., and others. This analysis provides insights into upcoming trends and challenges to aid strategic growth and opportunity leveraging.
A selection of companies mentioned in this report includes, but is not limited to:
- Ardigen S.A.
- BenevolentAI
- Freenome Holdings Inc.
- Google LLC
- Insilico Medicine
- International Business Machines Corp.
- Mediwhale Inc.
- Microsoft Corp.
- NVIDIA Corp.
- Owkin Inc.
- PathAI Inc.
- Qure.ai Technologies Pvt. Ltd.
- Shenzhen Jingtai Technology Co. Ltd.
- Syntekabio Inc.
- Tempus Labs Inc.
- TurinTech AI Inc.
For more information about this report visit https://www.researchandmarkets.com/r/q535eh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
